Exscientia plc (NASDAQ:EXAI – Get Rating)’s stock price rose 6.2% on Friday . The company traded as high as $6.53 and last traded at $6.48. Approximately 44,510 shares were traded during mid-day trading, a decline of 86% from the average daily volume of 319,182 shares. The stock had previously closed at $6.10.
Wall Street Analysts Forecast Growth
Separately, Barclays decreased their target price on Exscientia from $40.00 to $12.00 and set an “overweight” rating for the company in a research report on Wednesday, November 16th.
Exscientia Trading Up 11.0 %
The stock has a 50 day simple moving average of $6.75 and a 200-day simple moving average of $7.14. The firm has a market capitalization of $818.40 million, a P/E ratio of -3.40 and a beta of 0.47. The company has a current ratio of 7.55, a quick ratio of 7.55 and a debt-to-equity ratio of 0.01.
Institutional Investors Weigh In On Exscientia
Exscientia Company Profile
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection.
- Get a free copy of the StockNews.com research report on Exscientia (EXAI)
- MarketBeat Week in Review – 2/27 – 3/3
- The 3 Most Upgraded Stocks Are Reversing
- How to Find Blue Chip Dividend Stocks
- Zscaler, Inc Plummets, Is It Time To Buy The Dip?
- What is a Good Dividend Yield? How to Decide
Receive News & Ratings for Exscientia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exscientia and related companies with MarketBeat.com's FREE daily email newsletter.